PTC Therapeutics Huntington's disease drug shows promise in mid-stage trial

In this article:

June 21 (Reuters) - PTC Therapeutics Inc said on Wednesday interim data from a mid-stage study of its experimental drug to treat Huntington's disease demonstrated lowering the levels of mutated protein that causes the disease. (Reporting by Khushi Mandowara in Bengaluru)

Advertisement